
COVID-19èŠå¶ã«å察ããã«ããã®ãã©ãã¯é転ææè°ãã¢ã®ãªãŒããŒã3ã¶æã®èªå® è»çŠïŒãã®ä»
å èšäºã¯ãã¡ããã/Click here to read the original article.
The Defenderã®COVID NewsWatchã§ã¯ãSARS CoV-2ãŠã€ã«ã¹ã®èµ·æºãCOVIDã¯ã¯ãã³ãªã©ãSARS CoV-2ãŠã€ã«ã¹ã«é¢é£ããææ°ã®ãããã©ã€ã³ãäžæã«ç޹ä»ããŠããŸããä»ã®ãã¥ãŒã¹ãœãŒã¹ããã®æç²ã«ç€ºãããèŠè§£ã¯ãå¿ ãããThe Defenderã®èŠè§£ãåæ ãããã®ã§ã¯ãããŸããã
COVID-19èŠå¶ã«å察ããã«ããã®ãã©ãã¯é転ææè°ãã¢ã®ãªãŒããŒã«3ã¶æã®èªå® 謹æ åŠå
2022幎ã®COVID-19èŠå¶ã«å察ããã«ããã®ãã©ãã¯é転æã®æè°æŽ»åã§æãèåãªäººç©ã®äžäººãæ°Žææ¥ã3ã¶æã®èªå® 謹æ ãèšãæž¡ãããã
ãããã»ãã³ã°ïŒ47ïŒã¯11æããããããè£å€æåœä»€ã«åŸããªããªã©5ã€ã®åäºè²¬ä»»ã§æçœªå€æ±ºãåãããåœŒã¯æé«10å¹Žã®æ²åœ¹ã«çŽé¢ããŠããã
æ°Žææ¥ã®å€æ±ºã§ããªã³ã¿ãªãªå·é«çè£å€æã®è£å€å®ã¯ãã³ã°ã«ãè£å€ã®åãšè£å€äžã«ãã§ã«æçãããŠããæéãšããŠ9ã¶æã®åäœãäžãããèªå® 謹æ ã«å ãã圌ã¯ããŒããã³ã¯ãç·æ§çšã·ã§ã«ã¿ãŒã§100æéã®ç€ŸäŒå¥ä»æŽ»åãããªããã°ãªããªãã
ä»ã®2人ã®äž»å¬è ãã¿ãã©ã»ãªãããšã¯ãªã¹ã»ããŒããŒã¯è£å€ã®çµæãåŸ ã£ãŠãããããªãŒãã ã»ã³ã³ãã€ãšåä»ãããã2022幎2æã®æè°è¡åã¯ãã«ããæ¿åºãç±³å åœå¢ãè¶ãããã©ãã¯é転æã«ã¯ã¯ãã³æ¥çš®ã矩åä»ããããšã«ç«¯ãçºããŠããã
ããŒã·ã£ã«åžæ³é·å®ããã¡ãŠãã®COVID-19蚎èšã«é¢ããè€æ°ã®å·ã«ãã調æ»ã«åå
ã¡ãã·ã³æ¹Ÿå²žã¡ãã£ã¢ïŒ
ã¢ã©ããå·ã®ã¹ãã£ãŒãã»ããŒã·ã£ã«æ€äºç·é·ã¯å é±ãã¢ã³ãœããŒã»ãã¡ãŠãå士ã®COVID-19ãã³ãããã¯ã«å¯Ÿãã責任远åã®ãããå·æ€äºç·é·ã®é£åã«å ãã£ãã
ååŒè·å£«ã¯è°äŒæå°è ã«å®ãŠãæžç°¡ã®äžã§ãé£éŠæ¿åºã®ãã³ãããã¯å¯Ÿå¿ã«ããããã¡ãŠãå士ã®åœ¹å²ãåŒãç¶ã粟æ»ããããæ±ããå·ã¬ãã«ã®èª¿æ»ãè£ä»ãã蚌æ ãžã®ã¢ã¯ã»ã¹ãèŠæ±ããããã¥ãŒã¹ãªãªãŒã¹ã«ããã°ããã€ã¯ã»ãžã§ã³ãœã³äžé¢è°é·ãšãžã§ã³ã»ãã¥ãŒã³äžé¢é¢å ç·åå®ãŠã®æžç°¡ã¯ãäžé¢ã³ãããŠã€ã«ã¹ãã³ãããã¯ç¹å¥å°å§å¡äŒãCOVID-19ã®æ¿åºåŠçã«ãããäžæ£ã浪費ãä¹±çšãçºèŠããããšãç§°è³ããŠããã
å°å§å¡äŒã®èª¿æ»çµæã«ããã°ããã¡ãŠããšä»ã®é£éŠæ¿åºé¢ä¿è ã¯ãCOVID-19ã®èµ·æºã«ã€ããŠåœæ°ã欺ããæŠæŒ¢ã§ã®æ©èœç²åŸç ç©¶ã«å¯Ÿããåœç«è¡çç ç©¶æã®è³éæäŸã«ã€ããŠèåœã®èª¬æããããã³ãããã¯æ¿çãšã¯ã¯ãã³ã®ãªã¹ã¯ã«é¢ããç§åŠçè°è«ãæå§ãããªã©ã®äžæ£è¡çºãè¡ã£ãŠããã
ãã¢ã¡ãªã«åœæ°ã¯ããã³ãããã¯äžã«äžãããæ±ºå®ãã€ãŸãåœæ°ç掻ã®ããããåŽé¢ã«åœ±é¿ãåãŒããæ±ºå®ã«å¯ŸããŠãå®å šãªéææ§ãšèª¬æè²¬ä»»ãæããã¹ãã§ãããšããŒã·ã£ã«æ°ã¯ãªãªãŒã¹ã§è¿°ã¹ãã
女æ§ã¯é·ãCOVIDã®ãªã¹ã¯ãé«ãããšã¹ããã²ã³ãé¢äžããŠããå¯èœæ§ã
ã¯ã·ã³ãã³ã»ãã¹ãçŽïŒ
ç±³åœåœç«è¡çç ç©¶æãè³éãæäŸããé·COVIDç ç©¶ã€ãã·ã¢ããã§ããRECOVERã®æ°ããå šåœèª¿æ»ã«ãããšã女æ§ã¯ã©ã€ãã¹ããŒãžãéçµçµéšã®æç¡ã«ãã£ãŠãç·æ§ãããé·COVIDãçºçãããªã¹ã¯ãé«ãã
1æã«çºè¡šããããã®ç ç©¶ã¯ã12,000人以äžã®æäººã察象ã«è¡ããããã®ã§ãå šäœãšããŠãã³ãããŠã€ã«ã¹ã«ææããåŸã«é·ãCOVIDãçºçãããªã¹ã¯ã¯ãç·æ§ããã女æ§ã®æ¹ã31ïŒ é«ãããšãããã£ããéçµããŠããªã40æ³ãã54æ³ã®å¥³æ§ãæããªã¹ã¯ãé«ããå幎霢ã®ç·æ§ããã45ïŒ é«ã確çã§ãã³ã°ã³ãããçºçããã
ãããããã§ã«éçµãçµéšãã40æ³ãã54æ³ã®å¥³æ§ãš18æ³ãã39æ³ã®å¥³æ§ã§ã¯ãå幎霢局ã®ç·æ§ãšæ¯èŒããŠããã³ã°ã³ãããªã¹ã¯ã«ææå·®ã¯ãªãã£ãã
ã³ãããã¯ã¯ãã³æ¥çš®é«éœ¢è ã®å ¥é¢ãšæ»äº¡ã«å¯Ÿãããã¯ã¹ããããã®åœ±é¿ã¯ã以åèããããŠãããããã¯ããã«åŒ±ã
YubaNetïŒ
UCLAäž»å°ã®æ°ããç ç©¶ã«ãããšããã¯ã¹ãããã¯ã¯ã¯ãã³æ¥çš®ãåããé«éœ¢è ã®COVID-19ã«ããå ¥é¢ãšæ»äº¡ãææã«ã¯æžå°ãããªãã ãã®ç ç©¶ã¯ãã¯ã¯ãã³æªæ¥çš®ã®æäººã«ãããCOVID-19ã®å ¥é¢ãšæ»äº¡ãæžå°ããããã¯ã¹ãããã®æå¹æ§ãã¯ã¯ãã³æ¥çš®ãåããæäººã«ãé©çšããããšããä»®å®ã«çåãåããŠããããã¡ã€ã¶ãŒç€Ÿã®2022幎ã®èšåºè©Šéšã§ã¯ãã¯ã¯ãã³æªæ¥çš®ã®äžé«å¹Žæäººã«ãããCOVID-19ã«ããå ¥é¢ã®æžå°ãèªãããããããã®åŸã®2024幎ã®èšåºè©Šéšã§ã¯ãã¯ã¯ãã³æ¥çš®ãåããäžé«å¹Žæäººã§ã¯ææãªæžå°ã¯èªããããªãã£ãã
ã»ãšãã©ã®é«éœ¢è ã¯ãã§ã«2çš®é¡ä»¥äžã®COVID-19ã¯ã¯ãã³ãæ¥çš®ããŠãããããã¯ã¯ãã³æ¥çš®ãåããé«éœ¢è ã«å¯Ÿãããã¯ã¹ãããã®æå¹æ§ã¯éèŠãªæªè§£æ±ºåé¡ã®ãŸãŸã§ãã£ãã
ãéçCOVID-19ã®æã匷ãäºæž¬å åã¯é«éœ¢è ã§ããããããã¡ã€ã¶ãŒç€Ÿã®è©Šéšçµæãé«éœ¢è ãã¯ã¯ãã³æ¥çš®è éå£ã«äžè¬åãããã©ããã«ã€ããŠã®ãšããã³ã¹ãåŸãããšã¯æ¥µããŠéèŠã§ããããšãUCLAãã€ãããã»ã²ãã§ã³å»ç§å€§åŠäžè¬å ç§ã»å»çãµãŒãã¹ç ç©¶éšéã®å»åŠéšã¬ãžãã³ã¹åææã§ãããæ¬è©Šéšã®çé èè ã§ããJohn Mafiå士ã¯è¿°ã¹ãã
è¡ç®¡çæ£è ã¯è€æ°åã®COVIDã¯ã¯ãã³ããŒã¹ã¿ãŒãå¿ èŠ
MedscapeèªïŒ
è¡ç®¡çæ£è ãéçæ¥æ§åŒåžåšçå矀ã³ãããŠã€ã«ã¹2ïŒSARS-CoV-2ïŒææã«å¯Ÿããå ç«åå¿ã瀺ãããã«ãªããŸã§ã«ã¯ãå°ãªããšã3ã4åã®COVID-19ã¯ã¯ãã³æ¥çš®ãå¿ èŠã§ããããšããæ°ããç ç©¶ã§ç€ºåãããã
瞊æçã¬ããã¹ãã¯ãã£ãç ç©¶ã«ãããŠããŠã€ã«ã¹ã®ãªãã¯ãã³å€çš®ãšãã®åå«ã«å¯Ÿããè¡æž æäœäžåã¯ãæ£è ã«COVID-19ã¯ã¯ãã³ãæåã®2åæ¥çš®ããåŸã¯ãã»ãšãã©ãªããããšã倿ããããããã3åç®ãš4åç®ã®ã¯ã¯ãã³æ¥çš®åŸã«ã¯äžåæäœäŸ¡ã®äžæãèŠãããã
ãŸããB现èç Žå£çæ³ã§ãããªããã·ããã«ããæ²»çæŽãæµ ãã»ã©ãå ç«åæ§ã®ã¬ãã«ãäœããªããSARS-CoV-2ã«å¯Ÿããé²åŸ¡å¹æãäœããªãããšã瀺ãããã
5幎åŸãã¢ã¡ãªã«äººã¯ãã³ãããã¯ã倫婊仲ãåŒãè£ãããšèªã
CIDRAPïŒ
ãã¥ãŒã»ãªãµãŒãã»ã»ã³ã¿ãŒã®æ°ããäžè«èª¿æ»ã«ããã°ãã¢ã¡ãªã«äººã®72ïŒ ãããã³ãããã¯ã¯åœãã²ãšã€ã«ããããããåœãåè£ããããšçããŠããã75ïŒ ãCOVID-19ã¯èªåãã¡ã®çæŽ»ã«ææãäžãããšçããŠãããäžè«èª¿æ»ã¯2024幎10æäžæ¬ã«9,593人ã察象ã«è¡ãããã
äžè«èª¿æ»ã«ãããšã2020幎3æã«ãã³ãããã¯ãå ¬åŒã«å®£èšãããŠãã5幎çµã£ãä»ããã¢ã¡ãªã«ã¯æ°åã³ãããŠã€ã«ã¹ã®ç€ŸäŒç圱é¿ããçãããŠããããã¢ã¡ãªã«äººã¯æ°å幎ã«äžåºŠã®åºæ¥äºããå·Šå³ã®æ¿æ²»çåè£ãæ¿åºæ©é¢ãžã®äžä¿¡ãåœæ å ±ã®å°é ãå éãããèŠå ãšããŠæããŠããã
äžè«èª¿æ»ã®çµæãCOVID-19ã®å€§æµè¡ãèªåãã¡ã®çæŽ»ã«ææãäžãããšçãã4åã®3ã®ãã¡ã27ïŒ ã倧ããªææãåãã47ïŒ ãå°ããªææãåãããšçããã
éå»5幎éã«100äžäººä»¥äžã®ã¢ã¡ãªã«äººãCOVID-19ã§æ»äº¡ããããã«æ°çŸäžäººãé·æã®COVIDãšãšãã«ç掻ããŠããããçŸåšã§ã¯æäººã®5人ã«1人ïŒ21ïŒ ïŒããã³ãããŠã€ã«ã¹ãã¢ã¡ãªã«äººå šäœã®å¥åº·ã«ãšã£ãŠå€§ããªè åšã§ãããšçããŠããªãã
éåæ°ïŒ56ïŒ ïŒã¯ãã»ãšãã©ã®ã¢ã¡ãªã«äººãäœåºŠããŠã€ã«ã¹ã«ææããŠããããããã¯ãããŸãå¿é ããå¿ èŠã¯ãªããšçããŠããã
äžè«èª¿æ»ã®çµæãæ¿å å¥ã«èŠããšãå ±åå å¡ã®60ïŒ ãCOVID-19ã¯é¢šéªãã€ã³ãã«ãšã³ã¶ããæªããªããšçããããæ°äž»å å¡ã®76ïŒ ã¯ä»æ¥ã®COVID-19ã颚éªãã€ã³ãã«ãšã³ã¶ããæªããšè¡šçŸããŠããã
ã«ãŒãã®ãŒã¡ãã³å€§åŠãCOVIDæéäžã«é éææ¥ã«ç§»è¡ããåŠçã«480äžãã«ãæ¯æã
ã«ãŒãã®ãŒã¡ãã³å€§åŠã¯ã2020幎ã«COVID-19ã®æµè¡ãå§ãŸã£ãéãå¯Ÿé¢ææ¥ããªã³ã©ã€ã³ã«ç§»è¡ãããåŠçã®ããã«èµ·ããããéå£èšŽèšã®åè§£éãšããŠ480äžãã«ãæ¯æãããšã«åæããã
åè§£æ¡ã¯åååŽã®åæãåŸãŠããããããŒã°ã®é£éŠå°è£ã®ãããŒãã»Jã»ã³ã«ãŽã£ã«å€äºã«æåºãããæ¿èªããããåè§£ã¯ã©ã¹ã«ã¯æšå®13,337人ã®åŠçãå«ãŸããã
ã«ãŒãã®ãŒã¡ãã³å€§åŠïŒCMUïŒã®åŠçã®éå£èšŽèšã¯2020幎5æ15æ¥ã«æèšŽããããåŠçãã¡ã¯ã2020幎3æããCMUãCOVID-19ãã³ãããã¯ã«å¯Ÿå¿ããŠé éææ¥ãè¡ã£ããããææ¥æãææ°æããã®ä»ã®æéã®æãæ»ããåããæš©å©ããããšäž»åŒµãããéå£èšŽèšã§ã¯ã2020幎æ¥åŠæã®ææ¥æãšææ°æãæ¯æã£ãåŠçã¯ãCMUãšå¯Ÿé¢ææ¥ãåããæš©å©ãæããé»ç€ºã®å¥çŽãçµãã§ããããã³ãããã¯ã«å¯Ÿå¿ããŠé éæè²ã«åãæ¿ããããšã§ãCMUã¯ãã®é»ç€ºã®å¥çŽã«éåãããšäž»åŒµããã
åååŽã¯ãŸããé éæè²ãžã®ç§»è¡ã¯äžåœå©åŸãšè»¢æãããªãã¡èš±å¯ãªã財ç£ã奪ãè¡çºã«ããããšããŠãããCMUã¯äžæ£è¡çºã®ç³ãç«ãŠããã¹ãŠåŠå®ããŠããããããã以äžã®åºè²»ãäžäŸ¿ãè² æ ã蚎èšã®äžç¢ºå®æ§ãšãªã¹ã¯ãé¿ãããã ãã«ä»åã®åè§£ã«èžã¿åã£ããšè¿°ã¹ãŠããã
COVIDã§å€ãã®ã¢ã¡ãªã«äººãæ»äº¡ã瀟äŒä¿éè²»ã2050åãã«æŒãäžãã
COVID-19ã®ãã³ãããã¯ïŒäžçç倧æµè¡ïŒãå ¬åŒã«å§ãŸã£ãŠãã5幎ç®ãè¿ããããšããŠããããæ°ããç ç©¶ã«ããã°ããã®ãŠã€ã«ã¹ã«ãã£ãŠéåžžã«å€ãã®ã¢ã¡ãªã«äººãæ»äº¡ãããããåœã®ç€ŸäŒä¿éä¿¡èšåºéã¯ãéè·æåœãæ¯æãããªããªããæ°ååãã«ã®çŽå¢å ãèŠãããšã«ãªããšã®ããšã§ããã
å šç±³çµæžç ç©¶æïŒNational Bureau of Economic ResearchïŒã®ã¯ãŒãã³ã°ããŒããŒã«ããã°ããã³ãããã¯ã«é¢é£ãã25æ³ä»¥äžã®ã¢ã¡ãªã«äººã®è¶ éæ»äº¡ã¯ã2020幎ãã2023幎ã®éã«çŽ170äžäººã«ã®ãŒããšãããCOVID-19ã«é¢é£ããæ©ãããæ»äº¡ã¯ã瀟äŒä¿éå¶åºŠãå°æ¥ãããã®äººã ã«éè·éãæ¯æããªãããšãæå³ããçŽ2,940åãã«ã®æ¯æããæžå°ãããããšç ç©¶è ãã¡ã¯çºèŠããã
åæã«ããã®å©çã®äžéšã¯ããããã®äººã ãã倱ãããçšåãšãæ»äº¡è ã®é å¶è ãšåäŸãžã®éºæçµŠä»ã®å¢å ã«ãã£ãŠçžæ®ºãããå°æ¥ã®æ¯åºã¯æšå®ã§2,050åãã«æžå°ããã